Apeloa Pharma subsidiary receives cefixime capsule registration

Apeloa Pharmaceutical Co., Ltd. announced that its wholly-owned subsidiary, Zhejiang Jutai Pharmaceutical Co., Ltd., has received a Drug Registration Certificate from the National Medical Products Administration for cefixime capsules. The drug, a chemical medicine classified under Category 3, is indicated for infections caused by cefixime-sensitive bacteria, including bronchitis, pneumonia, and urinary tract infections.